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A False Positive 
18F-FDG PET/CT Scan
Caused by Breast Silicone Injection 
We present here the case of a 40-year-old woman with a greater than 10 year
prior history of bilateral breast silicone injection and saline bag implantation.
Bilateral palpable breast nodules were observed, but the ultrasound scan was
suboptimal and the magnetic resonance imaging showed no gadolinium-
enhanced tumor. The 
18F-FDG PET/CT scan showed a hypermetabolic nodule in
the left breast with a 30% increase of 
18F-FDG uptake on the delayed imaging,
and this mimicked breast cancer. She underwent a left partial mastectomy and
the pathology demonstrated a siliconoma.
lthough silicone injection for breast augmentation has numerous compli-
cations and it makes the exact diagnosis of breast cancer more difficult,
this procedure is not uncommon in Asia. 
18F-FDG PET is useful for differ-
entiating between benign and malignant lesions in many kinds of tumors, including
breast cancer. However, some kinds of inflammation can also show a high 
18F-FDG
uptake and so false results may occur. We herein present a case of a false positive
result on an 
18F-FDG PET scan that was caused by a previous silicone injection into the
breast.
CASE REPORT
A 40-year-old female with a history of bilateral breast silicone injection and saline
bag implantation (10 years previously) came to our hospital because of bilateral
palpable breast nodules. The ultrasound showed suboptimal findings due to silicone
injection and no abnormality could be found. The magnetic resonance imaging (MRI)
with gadolinium enhancement showed multiple non-enhanced silicone cysts, but no
gadolinium-enhanced breast tumor was noted. Owing to the clinically palpable breast
nodules, she was referred for 
18F-FDG PET/CT to determine the nature of the breast
nodules. One hour after intravenously injection of 370 MBq (10 mCi) of 
18F-FDG, an
integrated PET/CT scanner (Biograph; Siemens AG, Berlin, Germany) was used to
acquire the images from the head to the upper thighs. The attenuation correction was
done by CT. The delayed images were taken two hours post-injection. The images
were reconstructed using a standard ordered-subset expectation maximization
algorithm (two iterations, 8 subsets). The voxel size was 4.16×4.16×4.16 mm
3. 
18F-FDG PET/CT showed a hypermetabolic nodule in the left breast with a maximal
standardized uptake value (SUV) of 3.7 on the 1-hour post-injection image; the SUV
was calculated as tumor activity concentration/(injected dose/body weight) (Fig. 1).
The delayed 2-hour image showed a further increase of 
18F-FDG uptake in the nodule
Chao-Jung Chen, MD
1
Bi-Fang Lee, MD, PhD
1
Wei-Jen Yao, MD
1
Pei-Shan Wu, MD
1
Wen-Chung Chen, MD
2
Shu-Lin Peng, MD
2
Nan-Tsing Chiu, MD, MSc
1
Index terms:
Breast, siliconoma
18F-FDG PET/CT
DOI:10.3348/kjr.2009.10.2.194
Korean J Radiol 2009;10:194-196
Received May 7, 2008; accepted 
after revision July 30, 2008.
1Department of Nuclear Medicine,
National Cheng Kung University Medical
College and Hospital, Tainan, Taiwan
2Department of Pathology, National
Cheng Kung University Medical College
and Hospital, Tainan, Taiwan
Address reprint requests to:
Nan-Tsing Chiu, MD, Department of
Nuclear Medicine, Medical College,
National Cheng Kung University, 138
Sheng-Li Road, Tainan 704, Taiwan.
Tel. 886-6-235-3535 ext. 2474
Fax. 886-6-276-6609
e-mail: ntchiu@mail.ncku.edu.tw
AFalse Positive FDG PET/CT Caused by Breast Silicone Injection
Korean J Radiol 10(2), April 2009 195
AB
Fig. 1. False positive FDG PET/CT caused by breast silicone
injection in 40-year-old female.
A-C. Transverse slices of one hour post-injection 
18F-FDG PET
scan (A), CT (B) and PET/CT fusion image (C) showed focal area
of increased 
18F-FDG uptake (arrows; maximal SUV = 3.7) in left
breast anterolateral to saline bag. 
D. Delayed 
18F-FDG PET imaging at two hour post-injection
showed further increase of 
18F-FDG uptake in above lesion (arrow;
maximal SUV = 4.8).
E. Foreign body reaction to silicone (siliconoma). Variable-sized
silicone spaces were surrounded by multinucleated foreign body-
type giant cells, some foamy macrophages and some lympho-
cytes.
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with a maximal SUV of 4.8 (Fig. 1). Breast cancer was
highly suspected owing to the high, persistent rise of the
18F-FDG uptake in the lesion and its nodular shape. Thus,
we performed left partial mastectomy. However, the
pathology showed a siliconoma (silicone granuloma) and
there was no evidence of malignancy.
DISCUSSION
Silicone is one of several materials that are used for
breast augmentation. Silicone breast injection has
numerous adverse effects including skin reaction, pain,
infection and the formation of granulomas (i.e. siliconoma).
It also precludes the exact diagnosis of breast cancer
because injecting silicone makes the breast hard and lumpy
and a physical examination cannot differentiate it from
breast cancer. Performing mammography of breasts after
silicone injection often shows multiple dense nodules and
an accurate interpretation is difficult. The findings of
sonography are often suboptimal due to the extensive
echogenic noise of silicone (1). Although MRI in such cases
is considered valuable, it has also been reported that it is
difficult to differentiate malignancy from benign
angiogenic processes on MRI (2). 
18F-FDG PET has been shown to be useful to differentiate
benign lesions from malignant lesions in patients with
augmentation mammoplasty and it is superior to the more
traditional modalities (3, 4). However, false positive results
have been reported, such as a curvilinear-shaped increased
18F-FDG uptake around a ruptured breast prosthesis and
intense 
18F-FDG uptake in the ipsilateral axillary lymph
nodes of the ruptured breast implant (5, 6). The 
18F-FDG
uptake in the above-mentioned case was caused by inflam-
mation. Noh et al. (3) also demonstrated a case of false
positive results on 
18F-FDG PET from breast silicone
injection; however, in that case, there was no pathologic
report on the diffuse breast lesions with high 
18F-FDG
uptake. Our case did have pathologic proof. Besides, in our
case, the initial high 
18F-FDG uptake in the breast nodule,
as well as the further increase of 
18F-FDG accumulation in
the nodule on the additional delayed images, made
malignancy more likely. 
Dual-time-point imaging, with increasing and decreasing
18F-FDG uptake over time and this indicates breast
malignancy and inflammatory lesions, respectively, has
been reported to be highly sensitive and specific (7).
Nevertheless, our case demonstrated an inflammatory
lesion, which was ultimately proven to be a siliconoma
(silicone granuloma) caused by silicone injection, and this
led to a false positive result owing to a high and persistent
increase in 
18F-FDG uptake on the 
18F-FDG PET images. In
fact, some reports have indicated that some benign lesions,
such as a granulomatous pulmonary lesion, can show
further increase of 
18F-FDG uptake on the delayed images
(8). There have been reports of high levels of glucose
transporter-1 protein in inflammatory lesions that led to
high 
18F-FDG uptake (9) and a substantial expression of
hexokinase in the granulomatous tissue that contributed to
a persistent increase of 
18F-FDG uptake (10). These finds
can explain the initial high SUV uptake and a further
increase of 
18F-FDG uptake on the delayed image in our
case. Further investigations are needed on the usefulness of
dual-time-point 
18F-FDG PET in patients with a history of
breast silicone injection
In conclusion, we present here the case of a female
patient with a history of breast silicone injection that
caused a false positive 
18F-FDG PET/CT scan owing to the
injected silicone ’s high and persistently increasing SUV.
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